AnalyzeDirect Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, Gupta N, Berger MS, James CD. Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. J Neurosurg. September 2007;107(3):610-616.
Publication Date
September 2007
How Analyze was Used
“The images for each mouse were organized in spatial registration as a volume wrapper file, and each file was examined using Analyze 7.0 software to determine tumor volumes.”
Keywords
Animals
Antineoplastic Agents, Alkylating/therapeutic use
Brain Neoplasms/pathology/physiopathology/therapy
Dacarbazine/analogs & derivatives/therapeutic use
Disease Models, Animal
Glioblastoma/pathology/physiopathology/therapy
Luminescence
Luminescent Agents/diagnostic use
Mice
Mice, Nude
Monitoring, Physiologic/methods
Salvage Therapy
Xenograft Model Antitumor Assays
Author Affiliation(s)
Neuroscience Graduate Program, Mayo Clinic, Rochester, MN, US. (EBD)
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, US. (JNS, MAS, BLC)
Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco, CA, US. (RV, NG, MSB, CDJ)
ID# 1708
Tags: Alkylating/therapeutic use, Animal Disease Models, Animals, Antineoplastic Agents, Brain Neoplasms/pathology/physiopathology/therapy, Dacarbazine/analogs & derivatives/therapeutic use, Glioblastoma/pathology/physiopathology/therapy, Luminescence, Luminescent Agents/diagnostic use, Mice, Nude Mice, Physiologic Monitoring/methods, Salvage Therapy, Xenograft Model Antitumor Assays